Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Javier Díez-Domingo, Juan Carlos Tinoco, Airi Poder, Ener Cagri Dinleyici, Haylene Nell, Ignacio Salamanca de la Cueva, Tolga Ince, Edson Duarte Moreira$suffix/text()$suffix/text(), Khatija Ahmed, Kleber Luz, Yulia Kovshirina, Carlos Eduardo Medina Pech, Tauseefullah Akhund, Valerio Romolini, Marco Costantini, Thembile Mzolo, Barry Kunnel, Isabelle Lechevin, Marianna Aggravi, Paola Tiberi, K Narendran, Juan-Antonio García-Martínez, Venere Basile, Elena Fragapane, Maria Lattanzi & Michele Pellegrini. (2022) Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Pavitra Keshavan, Michele Pellegrini, Kumaran Vadivelu-Pechai & Michael Nissen. (2018) An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine. Expert Review of Vaccines 17:10, pages 865-880.
Read now
Read now
Xavier Saez-Llorens, Diana Catalina Aguilera Vaca, Katia Abarca, Emmanuelle Maho, Maria Gabriela Graña, Esther Heijnen, Igor Smolenov & Peter M Dull. (2015) Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents. Human Vaccines & Immunotherapeutics 11:6, pages 1507-1517.
Read now
Read now
Terry M Nolan, Michael D Nissen, Aftab Naz, Julie Shepard, Lisa Bedell, Matthew Hohenboken, Tatjana Odrljin & Peter M Dull. (2014) Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age. Human Vaccines & Immunotherapeutics 10:2, pages 280-289.
Read now
Read now
Articles from other publishers (13)
Tulika Mishra. (2023) Evaluation of the rate of Neisseria meningitides Infection in the United States from 2010 to 2020. IP International Journal of Medical Microbiology and Tropical Diseases 9:1, pages 66-69.
Crossref
Crossref
Puneet Vir Singh, Paola Tiberi, Gabriele Filippo Di Domenico, Valerio Romolini, Thembile Mzolo, Marco Costantini, Tauseefullah Akhund, Venere Basile, Maria Lattanzi & Michele Pellegrini. (2022) Fully Liquid MenACWY-CRM Vaccine: Results from an Integrated Safety Analysis. Drug Safety 46:1, pages 99-108.
Crossref
Crossref
Sandra Guedes, Isabelle Bertrand-Gerentes, Keith Evans, Florence Coste & Philipp Oster. (2022) Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature. BMC Public Health 22:1.
Crossref
Crossref
Corinne Vandermeulen, Isabel Leroux-Roels, James Vandeleur, Tommaso Staniscia, Ginette Girard, Murdo Ferguson, Giancarlo Icardi, Tino F Schwarz, A Munro Neville, Terry Nolan, Sandro Cinquetti, Tauseefullah Akhund, Sofie Van Huyneghem, Marianna Aggravi, Barry Kunnel, Bertrand de Wergifosse, Gabriele Filippo Di Domenico, Marco Costantini, Puneet Vir Singh, Elena Fragapane, Maria Lattanzi & Michele Pellegrini. (2021) A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study. Vaccine 39:45, pages 6628-6636.
Crossref
Crossref
Vittorio Gattini, Marco Napoletano, Alessandra Bonotti, Aldo Mignani, Francesca Cosentino, Giovanni Guglielmi, Poupak Fallahi, Alfonso Cristaudo & Rudy Foddis. (2021) Antimeningococcal Vaccination Coverage Among Healthcare Workers in an Italian University Hospital. Frontiers in Public Health 9.
Crossref
Crossref
Mostafa A. Elbahnasawy, Luke R. Donius, Ellis L. Reinherz & Mikyung Kim. (2018) Co-delivery of a CD4 T cell helper epitope via covalent liposome attachment with a surface-arrayed B cell target antigen fosters higher affinity antibody responses. Vaccine 36:41, pages 6191-6201.
Crossref
Crossref
Emile F.F. Jonker, Mariëtte B. van Ravenhorst, Guy A.M. Berbers & Leo G. Visser. (2018) Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines. Vaccine 36:26, pages 3727-3732.
Crossref
Crossref
Stan L. Block, Julie Shepard, Hartley Garfield, Fang Xie, Linda Han, Peter M. Dull & Igor Smolenov. (2016) Immunogenicity and Safety of a 3- and 4-dose Vaccination Series of a Meningococcal ACWY Conjugate Vaccine in Infants. Pediatric Infectious Disease Journal 35:2, pages e48-e59.
Crossref
Crossref
Stan L. Block, Leszek Szenborn, Wendy Daly, Teresa Jackowska, Diego D’Agostino, Linda Han, Peter M. Dull & Igor Smolenov. (2015) A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial. Vaccine 33:21, pages 2500-2510.
Crossref
Crossref
Martin Alberer, Gerd Burchard, Tomas Jelinek, Emil C. Reisinger, Seetha Meyer, Eduardo Forleo‐Neto, Alemnew F. Dagnew & Ashwani Kumar Arora. (2015) Immunogenicity and Safety of Concomitant Administration of a Combined Hepatitis A/B Vaccine and a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults. Journal of Travel Medicine 22:2, pages 105-114.
Crossref
Crossref
Anika Reinhardt, You Yang, Heike Claus, Claney L. Pereira, Andrew D. Cox, Ulrich Vogel, Chakkumkal Anish & Peter H. Seeberger. (2015) Antigenic Potential of a Highly Conserved Neisseria meningitidis Lipopolysaccharide Inner Core Structure Defined by Chemical Synthesis. Chemistry & Biology 22:1, pages 38-49.
Crossref
Crossref
Matthew C. Cook, Sabrina Gibeault, Vasilisa Filippenko, Qiang Ye, Junzhi Wang & Jeremy P. Kunkel. (2013) Serogroup quantitation of multivalent polysaccharide and polysaccharide-conjugate meningococcal vaccines from China. Biologicals 41:4, pages 261-268.
Crossref
Crossref
Ray Borrow. (2012)
Advances with vaccination against
Neisseria meningitidis
. Tropical Medicine & International Health 17:12, pages 1478-1491.
Crossref
Crossref